APA (7th ed.) Citation

Gabizon, A. A., Gabizon-Peretz, S., Modaresahmadi, S., & La-Beck, N. M. Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): An updated analysis and future perspective. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Gabizon, Alberto A., Shira Gabizon-Peretz, Shadan Modaresahmadi, and Ninh M. La-Beck. Thirty Years from FDA Approval of Pegylated Liposomal Doxorubicin (Doxil/Caelyx): An Updated Analysis and Future Perspective. BMJ Publishing Group.

MLA (9th ed.) Citation

Gabizon, Alberto A., et al. Thirty Years from FDA Approval of Pegylated Liposomal Doxorubicin (Doxil/Caelyx): An Updated Analysis and Future Perspective. BMJ Publishing Group.